Vimarsana
Biggest News Aggregation in the World

Aerogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aerogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aerogen Today - Breaking & Trending Today

Advertiser.ie - University of Galway crowned 2024 Purcell Cup champions - Vimarsana News

Advertiser.ie - University of Galway crowned 2024 Purcell Cup champions

University of Galway are set to return to top-flight camogie for third level education in 2025 after being crowned the 2024 Purcell Cup champions.

Advertiser.ie - University of Galway Camogie Club teams up with Aerogen - Vimarsana News

Advertiser.ie - University of Galway Camogie Club teams up with Aerogen

Ireland’s largest indigenous MedTech company, Aerogen, is the new sponsor of the University of Galway Camogie Club.

Prax Exploration & Production says will not lift Hurricane Energy bid - Vimarsana News

Prax Exploration & Production says will not lift Hurricane Energy bid

Hurricane Energy PLC's suitor on Monday said it will not lift its takeover offer, which has received an endorsement from shareholders Crystal Amber Fund Ltd and Kerogen Capital, as well as independent... | April 24, 2023

Qiagen acquires DNA-biometrics firm Verogen in $150 million deal - Vimarsana News

Qiagen acquires DNA-biometrics firm Verogen in $150 million deal

Life sciences firm Qiagen said on Monday it has acquired DNA-biometrics firm Verogen in a $150-million cash deal, strengthening its forensics portfolio. ... | January 9, 2023

World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen and CanSinoBIO, First Public Booster Immunization in China. - Vimarsana News

World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen and CanSinoBIO, First Public Booster Immunization in China.

Late in 2021, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO's Recombinant